1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases
5.1.1.2. Rising adoption of cancer therapeutic vaccines
5.1.1.3. Rising number programs to promote vaccination by WHO
5.1.2. Restraints
5.1.2.1. Low accessibility to vaccines in remote areas
5.1.3. Opportunities
5.1.3.1. Government initiatives for infectious diseases
5.1.3.2. Advancement in technology of emergin pathogens
5.1.4. Challenges
5.1.4.1. Complexity of production procedure of conjugate vaccine
5.2. Cumulative Impact of COVID-19

6. Conjugate Vaccine Market, by Type
6.1. Introduction
6.2. Monovalent
6.3. Multivalent

7. Conjugate Vaccine Market, by Indication
7.1. Introduction
7.2. Diphtheria and Pertussis
7.3. Influenza
7.4. Meningococcal
7.5. Pneumococcal

8. Conjugate Vaccine Market, by Pathogen Type
8.1. Introduction
8.2. Bacterial Conjugate Vaccine
8.3. Combination Conjugate Vaccine
8.4. Viral Conjugate Vaccine

9. Conjugate Vaccine Market, by End User
9.1. Introduction
9.2. Adults Conjugate Vaccine
9.3. Pediatrics Conjugate Vaccine

10. Americas Conjugate Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Conjugate Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Conjugate Vaccine Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Bharat Biotech
14.2. Biological E. Ltd
14.3. CSL Limited
14.4. GlaxoSmithKline, plc.
14.5. Merck and Company
14.6. Novartis AG
14.7. Nuron Biotech Inc.
14.8. Pfizer, Inc.
14.9. Sanofi Pasteur
14.10. Serum Institute of India

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL CONJUGATE VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONJUGATE VACCINE MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2027
FIGURE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2027 (%)
FIGURE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2027 (USD BILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2027
FIGURE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, 2018-2027 (USD BILLION)
FIGURE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2027 (%)
FIGURE 22. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2027
FIGURE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 25. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 31. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 VS 2027 (USD BILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2027
FIGURE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 34. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 36. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 37. AMERICAS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. ARGENTINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. BRAZIL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. CANADA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. MEXICO CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. UNITED STATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. CHINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. INDIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. INDONESIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. JAPAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. MALAYSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. SINGAPORE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. TAIWAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. THAILAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. FRANCE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. GERMANY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. ITALY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. QATAR CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. RUSSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. SPAIN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. GLOBAL CONJUGATE VACCINE MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL CONJUGATE VACCINE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONJUGATE VACCINE MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL CONJUGATE VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. AMERICAS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 19. ARGENTINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 20. BRAZIL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. CANADA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. MEXICO CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. UNITED STATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. CHINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. INDIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. INDONESIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. JAPAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. MALAYSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. SINGAPORE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. TAIWAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. THAILAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. FRANCE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. GERMANY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. ITALY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. QATAR CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. RUSSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. SPAIN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL CONJUGATE VACCINE MARKET: SCORES
TABLE 49. GLOBAL CONJUGATE VACCINE MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL CONJUGATE VACCINE MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL CONJUGATE VACCINE MARKET: RANKING
TABLE 52. GLOBAL CONJUGATE VACCINE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL CONJUGATE VACCINE MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL CONJUGATE VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL CONJUGATE VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL CONJUGATE VACCINE MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL CONJUGATE VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL CONJUGATE VACCINE MARKET: LICENSE & PRICING

Companies Mentioned

Bharat Biotech
Biological E. Ltd
CSL Limited
GlaxoSmithKline, plc.
Merck and Company
Novartis AG
Nuron Biotech Inc.
Pfizer, Inc.
Sanofi Pasteur
Serum Institute of India